Ambalal Sarabhai Enterprises Ltd share price logo

Ambalal Sarabhai Enterprises Ltd

NSE: AMBALALSA

BSE: 500009

Small Cap

Pharma Sector

₹39.50

+0.91

(+2.36%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Ambalal Sarabhai Enterprises shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-65%

Searches for Ambalal Sarabhai Enterprises on INDmoney have decreased by 65% over the last 30 days.

Ambalal Sarabhai Enterprises Stock Performance

as on September 16, 2026 at 6:41 pm IST

  • Day's Low

    Day's High

    ₹37.15
    ₹40.00
    downward going graph

    5.95%

    Downside

    1.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹30.15
    ₹49.98
    downward going graph

    23.67%

    Downside

    26.53%

    Upside

    downward going graph

Ambalal Sarabhai Enterprises share price movements today

Previous Close
₹38.59
Open
₹39.50
Volume
30.92K
Upper Circuit
₹40.51
Lower Circuit
₹36.67
Day's Low - High
₹37.15 - ₹40.00
52 Week Low - High
₹30.15 - ₹49.98

Ambalal Sarabhai Enterprises Historical Returns

1 Month Return
-15.56 %
3 Month Return
+ 19.92 %
1 Year Return
+ 25.21 %
3 Year Return
+ 6.69 %
5 Year Return
+ 30.59 %

Ambalal Sarabhai Enterprises Fundamentals

as on September 16, 2026 at 1:11 pm IST

Market Cap

₹295.73 Cr

Return on Equity (ROE)

7.67

PE Ratio (TTM)

23.72

Return on capital employed (ROCE)

6.77

Industry PE ratio

51.81

Beta (LTM)

11.73

P/B Ratio

3.13

Dividend Yield

0

PEG Ratio

593.09

Quarterly Earnings Growth YOY

-51.58

EPS (TTM)

2.32

Book Value

20.66

Ambalal Sarabhai Enterprises Stock Valuation

as on September 16, 2026 at 1:11 pm IST

Ambalal Sarabhai Enterprises in the last 5 years

  • Overview

  • Trends

Lowest (3.99x)

August 26, 2021

Today (23.72x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (184.16x)

February 7, 2024

LowHigh

Today’s Price to Earnings Ratio: 23.72x

Ambalal Sarabhai Enterprises Technical Analysis

Track how Ambalal Sarabhai Enterprises technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish6
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
0.04
Bearish
CCI (20)
-6.09
Neutral
RSI (14)
54.92
Neutral
Momentum (10)
-0.25
Neutral
ADI (14)
76.7
Neutral
Ultimate Oscillator (7,14,28)
33.26
Neutral

Moving Averages

Name

Value

Action

SMA (20)
39.54
Bearish
EMA (20)
39.5
Bullish
VWMA (20)
39.53
Bearish
SMA (50)
39.32
Bullish
EMA (50)
39.39
Bullish
SMA (200)
39.17
Bullish
EMA (200)
39.2
Bullish
KAMA (200)
39.52
Bearish
DEMA (200)
39.24
Bullish

Ambalal Sarabhai Enterprises Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ambalal Sarabhai Enterprises with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ambalal Sarabhai Enterprises Ltd image
Ambalal Sarabhai Enterprises Ltd
NA295.736.12%0.6317202
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Ambalal Sarabhai Enterprises Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
40.01
43.11
54.35
40.7
44.7
45.97
64.81
40.34
44.45
52
65.49
43.56
Other Income
2.85
1.63
4.79
2.3
2.8
5.76
1.63
8.36
1.62
2.76
3.02
2.46
Total Income
42.86
44.74
59.13
43
47.51
51.73
66.45
48.7
46.07
54.76
68.51
46.02
Expenses
39
40.58
49.69
40.22
42.17
46.67
66.52
38.88
44.09
48.74
59.79
39.02
Operating Profit
1.01
2.53
4.66
0.48
2.53
-0.7
-1.71
1.46
0.36
3.26
5.7
4.54
Operating Profit Margin %
2.52%
5.87%
8.57%
1.18%
5.66%
-1.52%
-2.64%
3.62%
0.81%
6.27%
8.7%
10.42%
Profit Before Interest, Tax and Depreciation
3.87
4.16
9.44
2.78
5.34
5.06
-0.07
9.82
1.98
6.02
8.72
7
Interest
0.92
0.99
0.9
0.95
1.22
1.14
0.96
1.01
0.96
0.7
1.42
0.98
Depreciation
1.14
1.13
0.25
0.98
1.01
0.99
1.02
0.88
1.06
0.96
1.05
1.35
Profit Before Tax
1.81
2.04
8.29
0.85
3.11
2.93
-2.05
7.93
-0.04
4.36
6.25
4.67
Tax Paid
0.72
0.7
-0.72
0.5
0.49
0.7
-1.78
-0.29
0.52
0.72
-0.25
0.7
Profit After Tax
1.08
1.33
9.02
0.35
2.62
2.23
-0.27
8.22
-0.56
3.64
6.5
3.98
Total Net profit including share of profit / Loss from associate company
1.08
1.33
9.02
0.35
2.62
2.23
-0.27
8.22
-0.56
3.64
6.5
3.98
EPS
0.14
0.15
1.18
0.05
0.34
0.29
-0.04
1.07
-0.07
0.4
0.85
0.52
Actual EPS
0.14
0.15
1.18
0.05
0.34
0.29
-0.04
1.07
-0.07
0.4
0.85
0.52
Adjusted EPS
0.14
0.15
1.18
0.05
0.34
0.29
-0.04
1.07
-0.07
0.4
0.85
0.52
Diluted EPS
0.14
0.15
1.18
0.05
0.34
0.29
-0.04
1.07
-0.07
0.4
0.85
0.52

Ambalal Sarabhai Enterprises Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
125.62
151.88
133.5
163.64
196.75
170.28
173.57
196.19
202.27
Other Income
25.23
7.72
24.39
39.69
48.44
12.49
10.37
12.02
15.59
Total Income
150.84
159.59
157.89
203.33
245.18
182.77
183.95
208.21
217.87
Expenses
137.4
146.04
137.07
165.43
186.97
162.41
169.96
195.1
191.33
Operating Profit
-11.78
5.84
-3.57
-1.79
9.78
7.87
3.61
1.09
10.94
Operating Profit Margin %
-9.38%
3.85%
-2.67%
-1.09%
4.97%
4.62%
2.08%
0.56%
5.41%
Profit Before Interest, Tax and Depreciation
13.45
13.56
20.82
37.9
58.21
20.36
13.98
13.11
26.54
Interest
3.36
3.25
3.32
2.95
1.7
2.44
3.76
4.26
4.09
Depreciation
2.12
2.1
2.57
2.41
2.32
2.76
3.57
4.01
3.94
Profit Before Tax
7.97
8.21
14.93
32.54
54.19
15.16
6.65
4.84
18.51
Tax Paid
6.69
3.97
0.88
3.18
6.98
3.72
0.98
-0.09
0.71
Profit After Tax
1.27
4.25
14.06
29.35
47.22
11.45
5.68
4.93
17.8
Total Net profit including share of profit / Loss from associate company
1.27
4.25
14.06
29.35
47.22
11.45
5.68
4.93
17.8
EPS
0.17
0.55
1.83
3.83
6.16
1.45
0.74
0.64
2.32
Actual EPS
0.17
0.55
1.83
3.83
6.16
1.45
0.74
0.64
2.32
Adjusted EPS
0.17
0.55
1.83
3.83
6.16
1.45
0.74
0.64
2.32
Diluted EPS
0.17
0.55
1.83
3.83
6.16
1.45
0.74
0.64
2.32

Ambalal Sarabhai Enterprises Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
-74.99
5.4
-7.39
18.8
-6.88
-2.3
11.47
5.72
8.89
-17.62
13.4
Cash Flow from Investing Activities
80.06
-3.31
17.75
-9.26
16.88
10.09
5.07
-16.79
-5.3
13.26
-10.26
Cash Flow from Financing Activities
-3.44
-6.26
-2.09
-6.07
-14.2
-5.84
-19.19
9.09
-2.95
-1.52
-1.85
Net Cash Flow
1.62
-4.17
8.1
3.49
-4.21
1.95
-2.64
-1.97
0.65
-5.88
1.3

Ambalal Sarabhai Enterprises Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
30.77%
30.77%
30.77%
31.35%
31.35%
31.35%
31.35%
31.35%
31.36%
31.36%
31.36%
DII
0.01%
0.01%
0.01%
0.01%
0.1%
0.1%
0.01%
0.01%
0.01%
0.01%
0.01%
FII
0%
0%
0%
0%
0%
0.38%
0.38%
0.34%
0.34%
0%
0%
Public
69.22%
69.22%
69.22%
68.65%
68.55%
68.17%
68.27%
68.31%
68.29%
68.64%
68.64%
Total Outstanding Shares
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
7,66,33,296
Total Shareholders
1,71,944
1,70,079
1,69,228
1,72,338
1,71,221
1,70,912
1,69,630
1,70,015
1,68,396
1,67,599
1,67,066

Ambalal Sarabhai Enterprises Corporate Actions

View detailed summary of the earnings and dividend history of Ambalal Sarabhai Enterprises.

  • Ambalal Sarabhai Enterprises Ltd Earnings Results

    Ambalal Sarabhai Enterprises Ltd’s net profit fell -51.58% since last year same period to ₹3.98Cr in the Q1 2026-2027. On a quarterly growth basis, Ambalal Sarabhai Enterprises Ltd has generated -38.77% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Ambalal Sarabhai Enterprises Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 68.64% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 25.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 31.36% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 150.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AMBALALSA stock has moved down by -9.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 68.51 Cr → 46.02 Cr (in ₹), with an average decrease of 32.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.5 Cr → 3.98 Cr (in ₹), with an average decrease of 38.8% per quarter

About Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Enterprises Ltd is a company that produces bulk drugs pharmaceutical preparations and electronic instruments. It operates in two segments - pharmaceuticals and electronics. Over the years, the company has collaborated with international organizations such as Biobras Brazil, B. V. Chiron, Netherlands, Chiron Corporation USA and has acquired companies like Suvik Hitek Pvt. Ltd., and Systronics India Pvt. Ltd. It has also opened a new company namely Vovanties Laboratories Pvt Ltd, and launched products such as Fludagem Xtinib. It was established in 1978, and converted into a public limited company in 1980. In 2010-11, it transferred and assigned its business and operations of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and its electronics division to Systronics India Ltd.

Revenue: ₹43.56Cr as on June 2026 (Q1 FY27)
Net Profit: ₹3.98Cr as on June 2026 (Q1 FY27)
Listing date: 10 May, 1995
Chairperson Name: Kartikeya V Sarabhai
OrganisationAmbalal Sarabhai Enterprises Ltd
IndustryPharmaceuticals
CEOKartikeya V Sarabhai
E-voting on sharesClick here to vote

FAQs

What is Ambalal Sarabhai Enterprises share price today?

Ambalal Sarabhai Enterprises share price today stands at ₹39.5 as on . Ambalal Sarabhai Enterprises share today touched a day high of ₹40 and a low of ₹37.15.

What is the 52 week high and 52 week low range for Ambalal Sarabhai Enterprises share?

Ambalal Sarabhai Enterprises touched a 52 week high of ₹49.98 and a 52 week low of ₹30.15. Ambalal Sarabhai Enterprises share price today i.e. is trending at ₹39.5, which is -20.97% down from its 52 week high and 31.01% up from its 52 week low.

What is Ambalal Sarabhai Enterprises's market capitalisation today?

Ambalal Sarabhai Enterprises market capitalisation is ₹295.73 Cr as on .

How to buy Ambalal Sarabhai Enterprises shares?

To buy Ambalal Sarabhai Enterprises shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AMBALALSA or Ambalal Sarabhai Enterprises Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ambalal Sarabhai Enterprises shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ambalal Sarabhai Enterprises trading volume today?

Ambalal Sarabhai Enterprises trading volume is 30.92K as on . This means that 30.92K shares of Ambalal Sarabhai Enterprises were bought and sold on the stock market during today's trading session.